Table 3

Modification of associations* between NO2 (per IQR of 5.8 μg/m3) and first asthma hospital admissions (n=977) by baseline characteristics and comorbid conditions among the 53 695 Diet, Cancer and Health cohort participants

CovariatesCovariate levelnHospitalisation rateHR (95% CI)p Value
GenderMale3851.51.19 (0.97 to 1.40)0.30
Female6122.21.09 (0.99 to 1.19)
Smoking statusNever3091.61.05 (0.90 to 1.20)0.31
Previous3182.11.17 (0.88 to 1.47)
Current3701.91.15 (0.85 to 1.43)
ETSYes6862.01.16 (0.88 to 1.44)0.24
No3111.61.04 (0.89 to 1.19)
Occupational exposureYes3902.31.07 (0.85 to 1.28)0.28
No6071.61.17 (1.06 to 1.27)
COPD (n=2139)Yes21911.01.30 (1.07 to 1.52)0.04
No7781.51.07 (0.98 to 1.17)
IHD (n=5458)Yes911.81.00 (0.70 to 1.30)0.35
No9011.91.14 (1.06 to 1.22)
Stroke (n=2542)Yes220.90.86 (0.27 to 1.46)0.36
No9751.91.13 (1.05 to 1.21)
Diabetes (n=5283)Yes721.30.87 (0.53 to 1.21)0.08
No9251.91.15 (1.07 to 1.23)
  • * Fully adjusted for smoking status (never, previous, current), smoking intensity, smoking duration, ETS, occupational exposure, gender, body mass index and educational level.

  • Crude hospitalisation rate per 1000 person-years.

  • For Wald test for interaction.

  • COPD, chronic obstructive pulmonary disease; ETS, environmental tobacco smoke; IHD, ischaemic heart disease; NO2, nitrogen dioxide.